Citadel Advisors »

Soleno Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $503k 13k 40.25
2023-09-30 $1.2M 41k 29.51

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Soleno Therapeutics

Vivo Capital
Carlyle
Perceptive Advisors
Nantahala Capital Management
Henderson Group
Vanguard Group
Balyasny Asset Management
venBio Select Advisor
Commodore Capital
Ikarian Capital
Frazier Life Sciences Management
Samlyn Capital
Emerald Advisers
Susquehanna International
Emerald Mutual Fund Advisers, Trust

View all funds holding Soleno Therapeutics